In order to assess the accuracy of various volumetric methods for screening and follow-up of prostatic disease, total prostate volume and inner zone volume were measured by transrectal ultrasonography in a screening population of 716 men. Semiplanimetric and caliper formula methods were compared wit
The role of prostatic planimetry using transrectal sonography in prostatic diseases
β Scribed by Hiroki Watanabe; Munekado Kojima
- Publisher
- John Wiley and Sons
- Year
- 1997
- Tongue
- English
- Weight
- 192 KB
- Volume
- 13
- Category
- Article
- ISSN
- 8756-0437
No coin nor oath required. For personal study only.
β¦ Synopsis
Transrectal sonography (TRS) remains the best method for prostatic planimetry, providing much information of value for the diagnosis and treatment of prostatic diseases, particularly of prostatic cancer. Currently, TRS is a routine tool in the detection and treatment of prostatic cancer. Prostatic planimetry is also available for a better understanding of elevated prostatespecific antigen (PSA). PSA indices modified by prostatic volume are applicable to the detection of prostatic cancer. The most critical application of prostatic planimetry is in monitoring prostatic cancer after treatment. Prostatic volume decreased exponentially after androgen deprivation therapy without exception in patients with prostatic cancer. The parameter "Ο" (Tau), calculated from kinetic analysis based on sequential planimetric volumetry using TRS after the initiation of treatment, is a reliable prognosticator in an individual patient. Furthermore, Ο predicts the manner of disease progression, and local or metastatic progression. Thus, transrectal ultrasonic prostatic planimetry is of special value in prostatic cancer.
π SIMILAR VOLUMES
Background. Prostate specific antigen (PSA) is useful as a tumor marker for monitoring patients with prostate cancer after definitive therapy. Limitations have been noted when PSA was used for the early detection of prostate cancer. The use of prostate specific antigen density [PSAD = PSA (ng/ml)/pr
The prostate gland of humans and many other animals has the major function of accumulating and secreting extraordinarily high levels of citrate. This specialized metabolic process of ''net citrate production'' is the result of unique metabolic capabilities of the secretory epithelial cells. Most imp
## BACKGROUND. Androgen deprivation is often used for the treatment of patients with prostate cancer. Androgen deprivation can be achieved by surgical castration or medical castration, with or without using an antiandrogen. Each of these treatments may be used alone, or an antiandrogen may be used